A recent report published by The Business Research Company on Cancer Diagnostics Market provides in-depth analysis of segments and sub-segments in the global as well as regional. The global cancer diagnostics market was valued at about $145.53 billion in 2018 and is expected to grow to $211.53 billion at a CAGR of 9.8% through 2022. The cancer diagnostics market consists of sales of cancer diagnostic devices and equipment. Cancer diagnostic equipment is used to identify biomarkers, proteins and symptoms in order to detect a cancerous tumor in the patient. Cancer diagnostics market is segmented into companion diagnostics and molecular diagnostics. View complete Report: https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report Major players in the market are Abbott, Becton Dickinson and Company , Hoffmann-La Roche Ltd, GE Healthcare Ltd., Thermo Fisher Scientific North America was the largest region in the cancer diagnostics ...
Your Landing Best Place to Purchase Global Market Research Reports